Skip to Main Content
Neal H. Steigbigel

Neal H. Steigbigel, MD

Professor, Department of Medicine

Keywords
antibiotic activity and mechanisms, bacterial sepsis, general ID
These focus areas and their associated publications are derived from medical subject headings from PubMed.
represents one publication
Loading...
*Due to PubMed processing times, the most recent publications may not be reflected in the timeline.

Professor, Department of Medicine

MD from Harvard Medical School

Fellowship, Harvard Medical Unit, Thorndike Memorial

Residency, Internal Medicine, Harvard Medical, Unit, Boston City Hospital

Steigbigel, Roy T; Steigbigel, Neal H

Clinical infectious diseases. 2019 Jan 07; 68(2):351-352

Drugs for cognitive loss and dementia

Bazil, Carl W.; Crouse, Ericka L.; Dalton, Vanessa K.; Epstein, Eric J.; Juurlink, David N.; Kim, Richard B.; Muggia, Franco M.; Mukherjee, Sandip K.; Roden, Dan M.; Schaefer, Esperance A.K.; Simons, F. Estelle R.; Steigbigel, Neal H.; Yee, Arthur M.F.

Medical letter on drugs & therapeutics. 2017 Sep 25; 59(1530):155-162

Sivapalasingam, Sumathi; Steigbigel, Neal H

Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA : Elsevier/Saunders, 2015. 8th edition. p.358-376.e6. (1686842)

Intravenous ibuprofen (Caldolor)

Abramowicz M.; Zuccotti G.; Pflomm J.-M.; Daron S.M.; Houst B.M.; Zanone C.E.; Hirsch J.; Mandell G.L.; Roden D.M.; Bazil C.W.; Dalton V.K.; Epstein E.J.; Juurlink D.N.; Kim R.B.; Meinertz H.; Mukherjee S.K.; Simons F.E.R.; Smoller J.W.; Steigbigel N.H.; Goodstein D.; Faucard A.; Covey C.M.; Teo V.; Wong S.; Donohue L.; Brown C.; Carbona G.; Romatowski C.; Valentino J.F.; Wissner-Levy Y.

Medical letter on drugs & therapeutics. 2010; 52(1329):3-4

Another once-daily formulation of tramadol (Ryzolt)

Abramowicz M.; Zuccotti G.; Pflomm J.-M.; Daron S.M.; Houst B.M.; Zanone C.E.; Shah B.M.; Hirsch J.; Mandell G.L.; Roden D.M.; Bazil C.W.; Dalton V.K.; Epstein E.J.; Juurlink D.N.; Kim R.B.; Meinertz H.; Mukherjee S.K.; Simons F.E.R.; Smoller J.W.; Steigbigel N.H.; Goodstein D.; Faucard A.; Covey C.M.; Teo V.; Wong S.; Donohue L.; Brown C.; Carbona G.; Romatowski C.; Valentino J.F.; Wissner-Levy Y.

Medical letter on drugs & therapeutics. 2010; 52(1338):39-40

When a statin fails

Abramowicz M.; Zuccotti G.; Pflomm J.-M.; Daron S.M.; Houst B.M.; Zanone C.E.; Hirsch J.; Mandell G.L.; Roden D.M.; Bazil C.W.; Dalton V.K.; Epstein E.J.; Juurlink D.N.; Kim R.B.; Meinertz H.; Mukherjee S.K.; Simons F.E.R.; Smoller J.W.; Steigbigel N.H.; Goodstein D.; Faucard A.; Covey C.M.; Teo V.; Wong S.; Donohue L.; Brown C.; Carbona G.; Romatowski C.; Valentino J.F.; Wissner-Levy Y.

Medical letter on drugs & therapeutics. 2009; 51(1317):58-60

Bimatoprost 0.03% solution (Latisse) for eyelash enhancement

Abramowicz M.; Zuccotti G.; Pflomm J.-M.; Daron S.M.; Houst B.M.; Zanone C.E.; Hirsch J.; Mandell G.L.; Roden D.M.; Bazil C.W.; Dalton V.K.; Epstein E.J.; Juurlink D.N.; Kim R.B.; Meinertz H.; Mukherjee S.K.; Simons F.E.R.; Smoller J.W.; Steigbigel N.H.; Schwartz L.K.; Cassagnol M.; Goodstein D.; Faucard A.; Covey C.M.; Wong S.; Donohue L.; Brown C.; Carbona G.; Romatowski C.; Valentino J.F.; Wissner-Levy Y.

Medical letter on drugs & therapeutics. 2009; 51(1313):43-44

Drugs for MRSA with reduced susceptibility to vancomycin

Abramowicz M.; Zuccotti G.; Pflomm J.-M.; Daron S.M.; Houst B.M.; Zanone C.E.; Bazil C.W.; Dalton V.K.; Epstein E.J.; Mukherjee S.K.; Smoller J.W.; Hirsch J.; Juurlink D.N.; Kim R.B.; Mandell G.L.; Meinertz H.; Roden D.M.; Simons F.E.R.; Steigbigel N.H.; Goodstein D.; Faucard A.; Covey C.M.; Schwartz L.K.; Cassagnol M.; Wong S.; Donohue L.; Brown C.; Carbona G.; Romatowski C.; Valentino J.F.; Wissner-Levy Y.

Medical letter on drugs & therapeutics. 2009; 51(1311):36-?